Mentioned in ?
References in periodicals archive ?
Current management of aggressive fibromatosis involves a multidisciplinary approach.
The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors) European Journal of Surgical Oncology.
A case report on aggressive fibromatosis with bone involvement.
Radiologically, the differential diagnosis includes neurogenic tumors, minor salivary gland tumors, dermoid or epidermoid tumors, hemangiomas, sarcoidosis, aggressive fibromatosis, dermatofibromas, fibrosarcomas, and malignant histiocytomas.
INTRODUCTION: Aggressive fibromatosis is a non-metastasizing tumor-like fibroblastic growth of unknown pathogenesis involving voluntary muscle as well as aponeurotic and facial structures.
The differential diagnosis as described in the literature includes fibroadenoma, malignant myoepithelioma, spindlecell carcinoma, aggressive fibromatosis, and various other myofibroblastic lesions (Table 1).
INTRODUCTION: Aggressive fibromatosis is a rare, locally aggressive disease.
Aggressive fibromatosis of the neck treated with a combination of chemotherapy and indomethacin
Deep fibromatosis, also known as aggressive fibromatosis or extraabdominal desmoid, is the most common soft-tissue tumor of the foot.
We present the case of a 23-year-old woman with aggressive fibromatosis of the oropharynx that was initially treated elsewhere as a peritonsillar abscess.
12] Radiotherapy as the treatment of aggressive fibromatosis has been used either as adjuvant therapy with surgery with positive margins or as primary therapy for extra-abdominal tumors that are unresectable or where surgery derived functional/cosmetic loss is unacceptable [12].
Aggressive fibromatosis describes the formation of a soft-tissue mass (desmoid tumor) that can be classified pathologically at any point along the spectrum between benign and malignant.

Full browser ?